SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in purkinje cells of SCA1 transgenic mice

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Spinocerebellar ataxia type 1 (SCA1) is one of several progressive neurodegenerative diseases caused by the expanded polyglutamine tract in ataxin-1, the SCA1 gene product. In SCA1 patients and transgenic mice, the affected neuronal cells contain a large ubiquitin-positive aggregate which is derived from the mutant ataxin-1. Small ubiquitin-like modifier-1 (SUMO-1) is one of the most intriguing ubiquitin-like modifiers being conjugated to target proteins and modulating a number of cellular pathways. Recent findings that the aggregates from several neurodegenerative diseases are SUMO-1-positive prompted us to examine the implication of SUMO-1 in SCA1 pathogenesis. In our yeast two-hybrid experiments using mutant ataxin-1 as bait, we identified a SUMO-1 protein that directly binds to ataxin-1 protein. Interestingly, we found that most of the mutant ataxin-1-derived aggregates were SUMO-1-positive both in Purkinje cells of SCA1 transgenic mice and in HeLa cells, but not wild-type ataxin-1 in HeLa cells. In addition, the aggregates in Purkinje cells of SCA1 transgenic mice were positive against both anti-SUMO-1 and anti-ubiquitin antibodies. These results show that the SUMO-1 protein interacts with mutant ataxin-1 and colocalizes with its aggregates which suggests the involvement of the SUMO-1 system in the pathogenesis of SCA1 disease.

Original languageEnglish
Pages (from-to)351-363
Number of pages13
JournalArchives Italiennes de Biologie
Volume148
Issue number4
Publication statusPublished - 2010

Keywords

  • Aggregates
  • Mutant ataxin-1
  • Polyglutamine
  • SCA1
  • SUMO-1

ASJC Scopus subject areas

  • Physiology
  • Cell Biology

Fingerprint Dive into the research topics of 'SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in purkinje cells of SCA1 transgenic mice'. Together they form a unique fingerprint.

Cite this